These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38050847)

  • 1. Editorial for "Hyperpolarized
    Robb FJL; Chen A
    J Magn Reson Imaging; 2024 Aug; 60(2):750-751. PubMed ID: 38050847
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperpolarized
    Gordon JW; Chen HY; Nickles T; Lee PM; Bok R; Ohliger MA; Okamoto K; Ko AH; Larson PEZ; Wang ZJ
    J Magn Reson Imaging; 2024 Aug; 60(2):741-749. PubMed ID: 38041836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
    Bowman AW; Bolan CW
    Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice.
    Kishimoto S; Brender JR; Crooks DR; Matsumoto S; Seki T; Oshima N; Merkle H; Lin P; Reed G; Chen AP; Ardenkjaer-Larsen JH; Munasinghe J; Saito K; Yamamoto K; Choyke PL; Mitchell J; Lane AN; Fan TW; Linehan WM; Krishna MC
    Elife; 2019 Aug; 8():. PubMed ID: 31408004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized
    Martinho RP; Bao Q; Markovic S; Preise D; Sasson K; Agemy L; Scherz A; Frydman L
    NMR Biomed; 2021 Feb; 34(2):e4446. PubMed ID: 33219722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extradomain-B Fibronectin-Targeted Dextran-Based Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Probe for Detecting Pancreatic Cancer.
    Han Z; Zhang S; Fujiwara K; Zhang J; Li Y; Liu J; van Zijl PCM; Lu ZR; Zheng L; Liu G
    Bioconjug Chem; 2019 May; 30(5):1425-1433. PubMed ID: 30938983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Computed Tomography and Magnetic Resonance Imaging in Accurate Size Estimation of Pancreatic Ductal Adenocarcinoma.
    Alabousi M; Patlas MN
    Can Assoc Radiol J; 2023 Aug; 74(3):478-479. PubMed ID: 36653945
    [No Abstract]   [Full Text] [Related]  

  • 8. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial for "MRI Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study".
    Yoshikawa T; Takenaka D; Ohno Y
    J Magn Reson Imaging; 2022 Mar; 55(3):840-841. PubMed ID: 35104005
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of residual tumor and overall survival after first-line surgery in patients with pancreatic ductal adenocarcinoma using preoperative magnetic resonance imaging findings.
    Bae JS; Kim JH; Kang HJ; Han JK
    Acta Radiol; 2022 Apr; 63(4):435-446. PubMed ID: 33682455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
    Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
    J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of three-dimensional fast imaging with steady precession dynamic MR imaging in evaluating pancreatic ductal adenocarcinoma.
    Irie H; Honda H; Aibe H; Kuroiwa T; Yoshimitsu K; Shinozaki K; Yamaguchi K; Shimada M; Masuda K
    Clin Imaging; 2001; 25(1):50-6. PubMed ID: 11435041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
    Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
    AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
    Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
    Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mimickers of pancreatic adenocarcinoma.
    Kothari K; Lopes Vendrami C; Kelahan LC; Shin JS; Mittal P; Miller FH
    Abdom Radiol (NY); 2020 May; 45(5):1387-1396. PubMed ID: 31559473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Ductal Adenocarcinoma With High Radiotracer Uptake in 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Sahbai S; Rieping P; Pfannenberg C; la Fougére C; Reimold M
    Clin Nucl Med; 2017 Sep; 42(9):717-718. PubMed ID: 28777194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.
    Wang ZJ; Behr S; Consunji MV; Yeh BM; Ohliger MA; Gao K; Ko AH; Cinar P; Tempero MA; Collisson EA
    AJR Am J Roentgenol; 2018 Nov; 211(5):1010-1019. PubMed ID: 30063366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
    Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
    Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Fat Content Detected by Computed Tomography and Its Significant Relationship With Intraductal Papillary Mucinous Neoplasm.
    Kashiwagi K; Seino T; Fukuhara S; Minami K; Horibe M; Iwasaki E; Takaishi H; Itoh K; Sugino Y; Inoue N; Iwao Y; Kanai T
    Pancreas; 2018 Oct; 47(9):1087-1092. PubMed ID: 30028443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiological evaluation of pancreatic ductal adenocarcinoma].
    Akai H; Otomo K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.